Lithium Primary Battery Industry - Strategy Analysis
The Global Lithium
Primary Battery Market size was valued at $2.5 billion in 2022, and is
projected to reach $3.9 billion by 2032, growing at a CAGR of 4.7% from 2023 to
2032. The increasing adoption of primary lithium batteries in medical devices
is expected to significantly drive the demand for the primary lithium batteries
market. Medical devices, ranging from life-saving implants like pacemakers and
insulin pumps to portable diagnostic equipment, rely on dependable power
sources to ensure continuous operation and patient safety. Primary lithium
batteries offer distinct advantages in this regard, including long shelf life,
high energy density, and stable voltage output throughout their lifespan. These
attributes are particularly critical for medical devices requiring extended
operational periods and reliability over time.
Recent Development
• In April
2022, Wuhan Fanshuo Technology launched the new lithium manganese battery CP9V
(Ver1.0). The new product is designed with a larger capacity, with its maximum
capacity continuing up to 1200 mAh and 120 mAh respectively.
• In March
2022, Saft opened a new lithium battery factory in Zhuhai Province, China. The
facility will double the company's production capacity to 60 million units per
year and is designed to meet rapid regional demand.
Comments
Post a Comment